(3.236.86.184)
[ij] [ij] [ij] 
Email id
 

Research Journal of Pharmacy and Technology
Year : 2023, Volume : 16, Issue : 4
First page : ( 1639) Last page : ( 1643)
Print ISSN : 0974-3618. Online ISSN : 0974-360X.
Article DOI : 10.52711/0974-360X.2023.00268

Formulation and characterization of two nystatin lozenge formulations as a new pharmaceutical dosage form in the syrian market

Alghanem Suhail H.*, Ibraheem Dimah N., Mansour Basem M., Shraiba Aktham N.

Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Al-Andalus University, Tartous, Syria

*Corresponding Author E-mail: sg4@au.edu.sy

Online Published on 13 October, 2023.

Abstract

The aim of this study was to prepare Nystatin lozenges (suitable for many age categories, easy to administrate and preferable in many medical cases) using a variety of excipients, then evaluate these formulations In vitro to select the best one for later use to treat Candida Albicans ( the cause of oral candidiasis). Two formulations were prepared, in F1 (only Arabic gum was used) while in F2 (Arabic gum with propylene glycol were used). A comparison was performed to evaluate the two formulations. The results of our comparison indicated that the F2 formula was the best (disintegrating time: 21.37±0.88 min, Td = 40.59 min is the time required to release 63.2% of the Nystatin content). Nystatin is released from the F2 formulation according to zero order kinetics (linearity between the amount of drug released with time).

Top

Keywords

Nystatin, Lozenges, In vitro, Release, Arabic gum.

Top

  
║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
813,775,189 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.